Biomarin Pharmaceutical Quote - B1MR34 | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
Brazil
BOV
Biomarin Pharmaceutical Inc (B1MR34) Share Price

Biomarin Pharmaceutical Inc (B1MR34)

191.52

0.00

(0.00%)

Closed 27 November 7:55AM

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

191.52

Bid

0.00

Offer

210.00

Volume

-

0.00 Day's Range 0.00

187.84 52 Week Range 258.34

Market Cap

Previous Close

191.52

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

161

Shares Outstanding

188,368,000

Dividend Yield

-

PE Ratio

72.90

Earnings Per Share (EPS)

0.89

Revenue

2.42B

Net Profit

167.65M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.biomarin.com

Headquarters

Wilmington, Delaware, USA

Founded

-

Biomarin Pharmaceutical Inc is listed in the Pharmaceutical Preparations sector of the Brazil Bovespa Exchange with ticker B1MR34. The last closing price for Biomarin Pharmaceutical was R$191.52. Over the last year, Biomarin Pharmaceutical shares have traded in a share price range of R$ 187.84 to R$ 258.34.

Biomarin Pharmaceutical currently has 188,368,000 shares in issue. The market capitalisation of Biomarin Pharmaceutical is R$36.08 billion. Biomarin Pharmaceutical has a price to earnings ratio (PE ratio) of 72.90.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	-1.52	-0.787401574803	193.04	198.74	191.52	67	193.00671642	DR
12	-66.82	-25.8651389642	258.34	258.34	187.84	161	214.81817131	DR
26	-18.48	-8.8	210	258.34	187.84	162	223.35821964	DR
52	-32.59	-14.5419659988	224.11	258.34	187.84	134	222.7560652	DR
156	-43.21	-18.4083841009	234.73	295.34	179.62	1653	223.49060823	DR
260	3.66	1.94825934206	187.86	348.85	179.62	1560	223.09877843	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MWET4Wetzel Sa (ex Metalurgica Wetzel Sa)	R$ 17.01 (30.85%)	11k
PPLA11PPLA Participations Ltd	R$ 2.25 (15.38%)	823
BHIA3Grupo Casas Bahia SA	R$ 4.09 (11.14%)	6.53M
BRAV3Brava Energia	R$ 20.86 (9.33%)	19.3M
VIVR3Viver Incorporadora e Construtora SA	R$ 1.43 (9.16%)	277k
RPAD3Alfa Holdings Sa (ex Real Sa Participacoes Administracao)	R$ 6.75 (-14.99%)	1.2k
ATOM3Atom Empreendimentos e Participacoes SA	R$ 4.19 (-10.47%)	342.7k
OSXB3OSX Brasil SA	R$ 3.96 (-8.97%)	27.3k
IFCM3Infracommerce Caxaas S.A.	R$ 0.11 (-8.33%)	1.87M
TRAD3TC S.A.	R$ 6.80 (-6.85%)	143.1k
COGN3CognaEducacao SA	R$ 1.47 (2.08%)	57.05M
HAPV3Hapvida Participacoes Investimento SA	R$ 3.05 (0.99%)	50.75M
CVCB3CVC Brasil Operadora E Agencia De Viagens SA	R$ 2.84 (3.27%)	44.95M
MGLU3Magaz Luiza	R$ 10.64 (6.29%)	36.38M
OIBR3Oi	R$ 1.69 (7.64%)	35.24M

WhirlwindCosmonaut85

WhirlwindCosmonaut85 4 minutes ago

https://lacdmhowr.powerappsportals.us/forums/support-forum/48a1e2c0-a5ac-ef11-b542-001dd8097a1a
https://lacdmhowr.powerappsportals.us/forums/support-forum/418da8cf-a4ac-ef11-b542-001dd8097a1a
https://lacdmhowr.powerappsportals.us/forums/support-forum/3a312712-a2ac-ef11-b542-001dd8097a1

TrendTrade2016

TrendTrade2016 6 minutes ago

maggot you made yet another fool out of yourself...A you can't short otc and B shorting the NASDAQ YOU need 200 GRAND IN YOUR MARGIN ACCOUNT AND THE ONLY STOCK YOU OWN IS THE SCAM AHRO...YOU LOST MOST OF YOUR MONEY IN THE MARKET AND YOU ARE A LYING POS...I CALLED THIS AT 1.90 IN PRE MARKET CLOWN B

Kenneth Howell

Kenneth Howell 9 minutes ago

Don’t be surprised if it sees 120 to 110 in the next 2 weeks. It does this after every earnings. Sells the news event. It usually bottoms 1 to 2 months after earnings then starts it rise to new highs . I have the December 110 puts. Will buy calls most likely in January. GLTA!

Bruno2

Bruno2 9 minutes ago

The table below shows currently available funds.

https://californiahvip.org/funding/

CaptainObvious

CaptainObvious 16 minutes ago

We're only allowed one sticky each. I have the Jama article.

Perhaps you or someone could compile a post containing all worthy to be stickied posts, with headings for each, and I can replace my current one.

Horseb4CarT

Horseb4CarT 17 minutes ago

Looks pretty useful however it keeps the details for those who pay for the research.

Any of you rich cats paid for the report and can share the details?

It seems like a big positive for dcvaxL and nwbo to be in the report, with dcvaxL listed first in the cancer vaccine

p0 17 minutes ago

IXCHIQ: Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA

https://valneva.com/press-release/valneva-submits-label-extension-application-for-its-chikungunya-vaccine-ixchiq-to-the-u-s-fda/

Saint Herblain (France), November 2

i_dont_know

i_dont_know 18 minutes ago

The reduction of liabilities is always a positive step since it eases the burden of interest expenses on the company’s results, especially when it comes to toxic financing like the Hypur convertibles. However, what good is reducing debt if there’s no clear business case in sight? Current and prospec

weedtrader420

weedtrader420 18 minutes ago

Edward

Edward 20 minutes ago

What???

No kidding!!!! That is just explaining that someone can sell a stock while it is in the Expert markrt!!

GEEZ!!!! OMG!

weedtrader420

weedtrader420 20 minutes ago

☝️🐶☝️✖️

ShawnP123

ShawnP123 26 minutes ago

It is sinking fast in the pre-market. This could be another $3-$6 red day. Jensen has a problem in regards to his Q conference. He needs professional help with what he should and how to report it. Instead his CFO Q&A was like using gasoline to put out a fire.

Budman33

Budman33 27 minutes ago

Maybe we close .0120 plus we were up over 40% @ one point late afternoon. Now when I dream I drop that first 0,,,, .12. Then wake up.

Truth and Transparency

Truth and Transparency 29 minutes ago

At the end of the day, Mark has come up short for the past 10 years. Payday loans to keep the lights on and a devastating share price as a result is what we have now.

NinjaFortress80

NinjaFortress80 31 minutes ago

https://lacdmhowr.powerappsportals.us/forums/support-forum/751aecbd-8fac-ef11-b542-001dd8097a1a
https://lacdmhowr.powerappsportals.us/forums/support-forum/79ad0f39-9bac-ef11-b542-001dd8097a1a
https://lacdmhowr.powerappsportals.us/forums/support-forum/9a793ccf-98ac-ef11-b542-001dd8097a1

Frankestin

Frankestin 36 minutes ago

Sun, no moon?
When F20?😤
When update website?
can you say something like we are still alive and working for the company?
☀️ 🙏 🌙 🤩

Roddy4

Roddy4 39 minutes ago

I cannot believe that Lalwani would sell his shares with an acquisition coming shortly. This doesn’t make any sense.

eagle8

eagle8 44 minutes ago

Thanks Astavaka.

https://www.issgovernance.com/eva/

GLTU

Seminole Red

Seminole Red 48 minutes ago

Trump transition team signs agreement to begin takeover from Biden

https://www.msn.com/en-us/news/politics/trump-transition-team-signs-agreement-to-begin-takeover-from-biden/ar-AA1uOexA?ocid=msedgntphdr&cvid=428e06a617894bb1e40a5b4dedbbe2f1&ei=55

rawsteel

rawsteel 50 minutes ago

Yes. I was able to place several trades at the same time. Didn't have to wait for order to fill but I thought it was still nonsense to limit the volume per trade...GLTU my friend....Happy Thanksgiving

jxyzobrien

jxyzobrien 53 minutes ago

tim ord

https://www.youtube.com/watch?v=P3ryc3iqHgI

Wayne R

Wayne R 54 minutes ago

I checked around, Beaujolais should be chilled for one hour in the fridge before being consumed, not more and not less, never at room temperature and never real cold.

Apparently it changes the taste.

Maybe try again using this information.

Saw bottles at

TRUSTUNITS1000000

TRUSTUNITS1000000 54 minutes ago

TRUSTUNITS1000000

TRUSTUNITS1000000 55 minutes ago

A lot of inventory left

Biomarin Pharmaceutical

Qsf - European High Yiel...

Exchange Traded Fund Ivz...

BlackRock Institutional ...

Fazenda Santa Rita PNC

First Trust S&p 500 Econ...

Dyne Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions